Commerzbank Aktiengesellschaft FI increased its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 71.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 41,436 shares of the real estate investment trust's stock after purchasing an additional 17,217 shares during the quarter. Commerzbank Aktiengesellschaft FI's holdings in Healthpeak Properties were worth $726,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of DOC. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Healthpeak Properties by 584.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust's stock worth $186,405,000 after purchasing an additional 7,872,150 shares during the period. Nuveen LLC acquired a new position in Healthpeak Properties during the first quarter worth about $124,113,000. Invesco Ltd. raised its stake in Healthpeak Properties by 20.7% during the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock worth $467,311,000 after acquiring an additional 3,967,830 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in Healthpeak Properties by 57.8% during the first quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust's stock worth $136,785,000 after acquiring an additional 2,477,307 shares in the last quarter. Finally, Amundi raised its stake in Healthpeak Properties by 89.4% during the first quarter. Amundi now owns 5,047,699 shares of the real estate investment trust's stock worth $98,228,000 after acquiring an additional 2,382,657 shares in the last quarter. Institutional investors own 93.57% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have commented on DOC. Scotiabank downgraded Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and lowered their target price for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Robert W. Baird set a $21.00 target price on Healthpeak Properties and gave the stock an "outperform" rating in a research note on Wednesday, July 30th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and set a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Morgan Stanley lowered their target price on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a research note on Friday, August 22nd. Finally, Cantor Fitzgerald began coverage on Healthpeak Properties in a research note on Wednesday, October 1st. They issued a "neutral" rating and a $20.00 price objective for the company. Eight investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $21.33.
Read Our Latest Report on Healthpeak Properties
Insiders Place Their Bets
In other Healthpeak Properties news, CEO Scott M. Brinker purchased 1,490 shares of the business's stock in a transaction on Monday, August 4th. The shares were purchased at an average cost of $16.83 per share, for a total transaction of $25,076.70. Following the acquisition, the chief executive officer owned 211,906 shares of the company's stock, valued at approximately $3,566,377.98. This represents a 0.71% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Over the last three months, insiders have purchased 8,783 shares of company stock worth $150,129. Corporate insiders own 0.23% of the company's stock.
Healthpeak Properties Stock Performance
NYSE:DOC opened at $18.04 on Friday. The company has a market capitalization of $12.53 billion, a PE ratio of 75.15, a P/E/G ratio of 3.15 and a beta of 1.09. The company has a 50 day simple moving average of $18.02 and a two-hundred day simple moving average of $17.98. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28. Healthpeak Properties, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. The business had revenue of $694.35 million during the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The company's revenue for the quarter was down .2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Announces Dividend
The company also recently announced a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be given a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 6.8%. The ex-dividend date of this dividend is Friday, December 19th. Healthpeak Properties's dividend payout ratio is currently 508.33%.
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.